These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 22596101)
1. Partial p16 staining in oropharyngeal squamous cell carcinoma: extent and pattern correlate with human papillomavirus RNA status. Lewis JS; Chernock RD; Ma XJ; Flanagan JJ; Luo Y; Gao G; Wang X; El-Mofty SK Mod Pathol; 2012 Sep; 25(9):1212-20. PubMed ID: 22596101 [TBL] [Abstract][Full Text] [Related]
2. Verrucous carcinomas of the head and neck, including those with associated squamous cell carcinoma, lack transcriptionally active high-risk human papillomavirus. Patel KR; Chernock RD; Zhang TR; Wang X; El-Mofty SK; Lewis JS Hum Pathol; 2013 Nov; 44(11):2385-92. PubMed ID: 24071016 [TBL] [Abstract][Full Text] [Related]
3. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials. Jordan RC; Lingen MW; Perez-Ordonez B; He X; Pickard R; Koluder M; Jiang B; Wakely P; Xiao W; Gillison ML Am J Surg Pathol; 2012 Jul; 36(7):945-54. PubMed ID: 22743284 [TBL] [Abstract][Full Text] [Related]
4. p16 immunohistochemistry in oropharyngeal squamous cell carcinoma: a comparison of antibody clones using patient outcomes and high-risk human papillomavirus RNA status. Shelton J; Purgina BM; Cipriani NA; Dupont WD; Plummer D; Lewis JS Mod Pathol; 2017 Sep; 30(9):1194-1203. PubMed ID: 28621317 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma. Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895 [TBL] [Abstract][Full Text] [Related]
6. Histologic Typing in Oropharyngeal Squamous Cell Carcinoma: A 4-Year Prospective Practice Study With p16 and High-Risk HPV mRNA Testing Correlation. Gondim DD; Haynes W; Wang X; Chernock RD; El-Mofty SK; Lewis JS Am J Surg Pathol; 2016 Aug; 40(8):1117-24. PubMed ID: 27035614 [TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas. Rietbergen MM; Snijders PJ; Beekzada D; Braakhuis BJ; Brink A; Heideman DA; Hesselink AT; Witte BI; Bloemena E; Baatenburg-De Jong RJ; Leemans CR; Brakenhoff RH Int J Cancer; 2014 May; 134(10):2366-72. PubMed ID: 24249631 [TBL] [Abstract][Full Text] [Related]
8. High-risk human papillomavirus is transcriptionally active in a subset of sinonasal squamous cell carcinomas. Larque AB; Hakim S; Ordi J; Nadal A; Diaz A; del Pino M; Marimon L; Alobid I; Cardesa A; Alos L Mod Pathol; 2014 Mar; 27(3):343-51. PubMed ID: 24030745 [TBL] [Abstract][Full Text] [Related]
9. Utility of p16 and HPV testing in oropharyngeal squamous cell carcinoma: An institutional review. Abdelhakam DA; Huenerberg KA; Nassar A Diagn Cytopathol; 2021 Jan; 49(1):54-59. PubMed ID: 32845095 [TBL] [Abstract][Full Text] [Related]
10. RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization. Rooper LM; Gandhi M; Bishop JA; Westra WH Oral Oncol; 2016 Apr; 55():11-6. PubMed ID: 27016012 [TBL] [Abstract][Full Text] [Related]
11. Correlation of p16 immunostaining in cell-blocks with corresponding tissue specimens for squamous cell carcinomas of the oropharynx. Song SJ; Jalaly JB Cytopathology; 2021 Jan; 32(1):100-107. PubMed ID: 32886831 [TBL] [Abstract][Full Text] [Related]
12. Significance of transcriptionally-active high-risk human papillomavirus in sinonasal squamous cell carcinoma: Case series and a meta-analysis. Svajdler M; Nemcova J; Dubinsky P; Metelkova A; Svajdler P; Straka Ľ; Sakar R; Daum O; Michal M; Skalova A; Mezencev R Neoplasma; 2020 Nov; 67(6):1456-1463. PubMed ID: 32853018 [TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinoma. Kawakami H; Okamoto I; Terao K; Sakai K; Suzuki M; Ueda S; Tanaka K; Kuwata K; Morita Y; Ono K; Nishio K; Nishimura Y; Doi K; Nakagawa K Cancer Med; 2013 Dec; 2(6):933-41. PubMed ID: 24403267 [TBL] [Abstract][Full Text] [Related]
14. ROC analysis of p16 expression in cell blocks of metastatic head and neck squamous cell carcinoma. Wilson BL; Israel AK; Ettel MG; Lott Limbach AA J Am Soc Cytopathol; 2021; 10(4):423-428. PubMed ID: 33906829 [TBL] [Abstract][Full Text] [Related]
15. Oropharyngeal Squamous Cell Carcinoma With Discordant p16 and HPV mRNA Results: Incidence and Characterization in a Large, Contemporary United States Cohort. Shinn JR; Davis SJ; Lang-Kuhs KA; Rohde S; Wang X; Liu P; Dupont WD; Plummer D; Thorstad WL; Chernock RD; Mehrad M; Lewis JS Am J Surg Pathol; 2021 Jul; 45(7):951-961. PubMed ID: 33739785 [TBL] [Abstract][Full Text] [Related]
16. Biomarkers of HPV in head and neck squamous cell carcinoma. Liang C; Marsit CJ; McClean MD; Nelson HH; Christensen BC; Haddad RI; Clark JR; Wein RO; Grillone GA; Houseman EA; Halec G; Waterboer T; Pawlita M; Krane JF; Kelsey KT Cancer Res; 2012 Oct; 72(19):5004-13. PubMed ID: 22991304 [TBL] [Abstract][Full Text] [Related]
17. Undifferentiated carcinoma of the oropharynx: a human papillomavirus-associated tumor with a favorable prognosis. Carpenter DH; El-Mofty SK; Lewis JS Mod Pathol; 2011 Oct; 24(10):1306-12. PubMed ID: 21572403 [TBL] [Abstract][Full Text] [Related]
18. Detection and significance of human papillomavirus, CDKN2A(p16) and CDKN1A(p21) expression in squamous cell carcinoma of the larynx. Chernock RD; Wang X; Gao G; Lewis JS; Zhang Q; Thorstad WL; El-Mofty SK Mod Pathol; 2013 Feb; 26(2):223-31. PubMed ID: 22996374 [TBL] [Abstract][Full Text] [Related]
19. The role of human papillomavirus in p16-positive oral cancers. Belobrov S; Cornall AM; Young RJ; Koo K; Angel C; Wiesenfeld D; Rischin D; Garland SM; McCullough M J Oral Pathol Med; 2018 Jan; 47(1):18-24. PubMed ID: 29024035 [TBL] [Abstract][Full Text] [Related]
20. p16 immunostaining in cytology specimens: its application, expression, interpretation, and challenges. Ribeiro EA; Maleki Z J Am Soc Cytopathol; 2021; 10(4):414-422. PubMed ID: 33422456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]